Genus (LON:GNS – Get Free Report) had its price objective upped by equities research analysts at Deutsche Bank Aktiengesellschaft from GBX 3,100 to GBX 3,300 in a research report issued to clients and investors on Friday,Digital Look reports. The brokerage currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential upside of 16.40% from the company’s previous close.
GNS has been the topic of a number of other reports. Berenberg Bank raised their target price on shares of Genus from GBX 3,050 to GBX 3,250 and gave the stock a “buy” rating in a research report on Friday. Shore Capital reiterated a “buy” rating and issued a GBX 3,000 price target on shares of Genus in a research report on Friday. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of GBX 3,183.33.
Get Our Latest Research Report on GNS
Genus Stock Performance
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Read More
- Five stocks we like better than Genus
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
